TVTX Stock Analysis: Buy, Sell, or Hold?
TVTX - Travere Therapeutics, Inc. Common Stock
$31.09
-0.90 (-2.81%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 19, 2026
18d
Get Alerted When TVTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called TVTX this week
0% bullish • 1 bearish
0% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TVTX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: TVTX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$67.98
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$42.21
26.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TVTX is currently trading at $31.09, which is considered slightly low relative to its 30-day fair value range of $29.27 to $37.69. The stock's valuation (Forward PE: 16.9) is in line with its historical norms (18.4). Remarkably, the market is currently pricing in an annual earnings decline of 2.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TVTX is in a strong uptrend. Immediate support is located at $26.78, while resistance sits at $32.11.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.07 (+31.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TVTX is in a strong uptrend. Immediate support is located at $26.78, while resistance sits at $32.11.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.07 (+31.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$29.27 -
$37.69
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 31.5% below Wall St target ($42.07)
Fair Price Analysis
30-Day Fair Range
$29.27 -
$37.69
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$26.78
Resistance Level
$32.11
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
16.86
Wall Street Target
$42.07
(+31.5%)
Revenue Growth (YoY)
162.1%
Profit Margin
-20.3%
Valuation Discount vs History
-2.8% cheaper
PE vs Historical
16.9 vs 18.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.8%
(market-implied from PE analysis)
1-Year Target
$31.09
(-3%)
2-Year Target
$30.22
(-6%)
3-Year Target
$29.38
(-8%)
3-Yr Target (if PE normalizes)
(PE: 17→18)
$32.06
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 108.2%)
$142.78
(+346%)
Base:
(SPY PE: 16.9, Growth: 108.2%)
$107.97
(+238%)
Bear:
(PE: 14.3, Growth: 108.2%)
$91.77
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.9 to 18.4
Stabilization Target:
$34.91
(+9.1%)
PE Expansion Potential:
+9.1%
Last updated: January 31, 2026 12:11 AM ET
Data refreshes hourly during market hours. Next update: 1:11 AM
Data refreshes hourly during market hours. Next update: 1:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TVTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Elizabeth E Reed
SELL
10000 shares
2025-09-22
Christopher R Cline
SELL
119 shares
2025-09-04
Christopher R Cline
SELL
454 shares
2025-09-03
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
Advanced TVTX Option Strategies
Professional options setups generated by AI based on today's TVTX price and gamma walls.
